Global medical cannabis Target a multinational distributor or pharmacy network to scale Tikun Olam California’s medically-focused cannabis products beyond the US, leveraging their Israel roots and R&D credibility to secure partnerships and co-branding opportunities.

Small high-impact With a lean team (11-50 employees) and $10M–$25M revenue, pursue strategic deals with larger contract manufacturers, white-label opportunities, or outsourced R&D services to expand capacity and accelerate product development without proportionally increasing headcount.

Research backed Position the company’s decade-plus of research as a differentiator to win collaborations on clinical studies, dosing research, and quality assurance programs with hospitals, clinics, or academic partners seeking evidence-based medical cannabis solutions.

Tech-enabled Leverage current tech stack and cloud/web infrastructure to offer seamless digital collaboration, CRM integration, and compliant patient education platforms as value-adds in partnerships with distributors and healthcare providers.

Growth signals With revenues in the mid-range and comparable peers that are much larger, pursue investment or strategic fundraising conversations to fuel expansion, scale production, and enter new markets while showcasing scalable operations and growth trajectory.